Successful production of H5N1 vaccine

Following the success of the National Institute of Hygiene and Epidemiology in the study of the production of H5N1 flu vaccine by the technology of culturing on monkey kidney cells, scientists at three research and production agencies of Vietnam have simultaneously announced the introduction of the first batch of vaccines to prevent H5N1 flu for both humans and poultry with culture technology on embryonic chicken eggs.

Vaccination of vaccine production into chicken embryos at the Institute of Biotechnology (Photo: TTO) It is a product of the Institute of Vaccines and Biological Products in Nha Trang, Hoai Duc Veterinary Drug Factory, Ha Tay (Veterinary Institute Central) and Central Veterinary Medicine Company (Navetco) in Ho Chi Minh City.

This success with the success of the National Institute of Hygiene and Epidemiology has strengthened the belief that Vietnam can fully self-vaccinate in case of pandemic H5N1 pandemic.

Assoc. Dr. Dinh Duy Khang - Head of the Division of Molecular Microbiology, Institute of Biotechnology (Biotechnology) - said since 2005, after finding out and knowing the World Health Organization (WHO) recommends countries. study to be able to produce H5N1 influenza vaccine itself, Assoc. Dr. Le Tran Binh - Director of the Institute of Biotechnology - actively contacted WHO to propose the transfer of seed strains for vaccine production research.

After signing the Memorandum of Understanding, the Institute of Biotechnology was transferred by the WHO to the study of vaccine production (NIBRG-14 strain) through the National Institute of UK Biological Standards and Inspection (NIBSC).

Mr. Khang said that after receiving the strain, the Institute of Biotechnology has researched breeding, creating production batches to supply vaccine production facilities.

The estimated price of domestically produced H5N1 vaccines is lower than the imported price. However, the most important thing is that Vietnam can take initiative in vaccines when epidemics occur, avoiding the shortage of vaccines or having to massively import vaccines with large volumes in a short time beyond the ability to test beating. quality prices of domestic vaccine testing facilities.

HUNG HUNG